CDK12-BRCA1信号轴通过p53-介导的细胞衰老来调解与dinaciclib相关的放射敏感性
Natalia García Flores1,2, Diego M Fernández-Aroca1,2,3, Cristina Garnés-García1,2,4
1Laboratorio de Oncología Molecular, Unidad de Medicina Molecular, Instituto de Biomedicina, Universidad de Castilla-La Mancha, Albacete, Spain.
Molecular oncology
|December 3, 2024
概括
迪纳西克利布通过抑制CDK12和影响DNA修复途径来增强某些癌症的辐射敏感性. 这一发现支持基于瘤遗传学的个性化癌症治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 辐射疗法 辐射疗法
背景情况:
- 泛环素依赖激酶 (CDK) 抑制剂,如迪纳西克利布,代表了一个新的向治疗类别.
- 将迪纳西克利布与放射治疗结合在一起是一个尚未探索的治疗策略.
研究的目的:
- 在实验癌症模型中研究将迪纳西克利布与电离辐射结合的疗效.
- 阐明dinaciclib对辐射敏感性的作用背后的分子机制.
主要方法:
- 用迪纳西克利布和电离辐射治疗肺癌和结肠癌细胞系 (A549,HCT 116,H1299,HT-29).
- 对DNA损伤信号 (ATM),细胞周期进展,细胞亡和DNA修复途径 (HR,NHEJ) 的分析.
- 评估BRCA1表达及其在辐射敏感化中的作用.
主要成果:
- 迪纳西克利布在A549和HCT 116细胞中增加了辐射敏感性,但在H1299或HT-29细胞中没有.
- 这种组合在辐射后没有改变ATM信号或细胞周期概况.
- 迪纳西克利布抑制了CDK12,减少了BRCA1的表达,损害了同源重组 (HR),并以TP53依赖的方式促进衰老.
结论:
- CDK12-BRCA1轴调解dinaciclib的放射敏感作用,影响DNA修复途径.
- 这种机制解释了基于瘤遗传特征的迪纳西克利布和放射治疗的不同反应.
- 这些发现支持针对个体瘤特征量身定制的个性化放射治疗策略.
相关概念视频
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


